NCT05840757View on ClinicalTrials.gov

Non-Invasive MOnitoring in Transcathether Aortic Valve Implantation

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2023

Primary Completion Date

December 30, 2023

Study Completion Date

December 31, 2023

Conditions
Aortic Valve Disease
Interventions
DEVICE

HemoSphere ClearSight Module

The Clear Sight system consists of a finger cuff connected to a monitor It will be applied to the patients finger before and removed after the TAVI procedure.

Trial Locations (1)

4031

University Hospital Basel, Basel

All Listed Sponsors
lead

University of Basel

OTHER